ARCA biopharma, Inc. Skyrocketed

Wed, Sep 04, 2024 at 07:41 PM

ARCA biopharma, Inc. (ABIO:NASDAQ) shot up at $28.8, representing a gain of 1052%. On Wed, Sep 04, 2024, ABIO:NASDAQ hit a New 2-Week Intraday Low of $2.25. The stock got featured on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Wed, Aug 21, 2024, the stock recorded 44.44% Up Days and 70.00% Green Days

About ARCA biopharma, Inc. (ABIO:NASDAQ)

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

Top 10 Gainers:

ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
Summit Wireless Technologies, Inc. (WISA:NASDAQ), 125%
Kubient Inc. (KBNT:NASDAQ), 100%
BOQI International Medical Inc. (BIMI:NASDAQ), 60%
Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 52.77%
180 Life Sciences Corp. (ATNF:NASDAQ), 41.24%
Frontier Communications Parent Inc. (FYBR:NASDAQ), 37.95%
Tantech Holdings Ltd (TANH:NASDAQ), 34.53%
Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 32.89%
Top Wealth Group Holding Limited (TWG:NASDAQ), 32.5%